ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Belldegrun's Allogene looks to poach veteran biotech analyst for CFO: Stat
May 08, 2018Former Kite execs Arie Belldegrun and David Chang splashed back onto the scene last month with a new startup, an array of off-the-shelf CAR-T assets and $300 million to bankroll it all. Now, Stat reports, Belldegrun is looking to sign on Cowen analyst Eri
Pharma Sources Insight January 2025
